Kala shares soar after FDA approves trial for drug to treat PCED 0 28.12.2022 23:27 CBSNews.com Biotech firm developing potential treatment for rare eye disease called "persistent corneal epithelial defect." Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
